CIPLA MEDPRO SOUTH AFRICA LIMITED - Cipla Medpro TRP investigation
CMP 201209210051A
Cipla Medpro TRP investigation
Cipla Medpro South Africa Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
Share code: CMP
ISIN: ZAE000128179
(“Cipla Medpro” or the "Company")
Cipla Medpro TRP investigation
Shareholders are advised that the Company has received notification from the Takeover Regulation
Panel (“TRP”) that it intends to conduct an investigation into the affairs of Cipla Medpro relating to a
potential affected transaction. The complaint was lodged on behalf of certain shareholder/s,
amongst whom includes the Company’s suspended CEO, Mr Smith, in his capacity as a shareholder.
The details of the other shareholder/s have not yet been disclosed to the TRP.
The Company has confirmed to the TRP that it will cooperate in any way possible to ensure this
matter is resolved as quickly as possible and has provided some background information to the
representatives of the TRP. The Company is now awaiting confirmation from the TRP as to how and
when the investigation will proceed. The board will continue to advise shareholders of any
developments in this regard.
Bellville
21 September 2012
Sponsor
Nedbank Capital
Date: 21/09/2012 04:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
